US Corporate Distress Financial Stress SEC Filings — July 09, 2026

09-07-2026

Shutterstock, Inc. announced the termination of its merger agreement with Getty Images Holdings, Inc., originally entered into on January 6, 2025. The termination followed the U.K. Competition and Markets Authority's conditional clearance requiring the sale of Shutterstock's editorial business, which Getty Images' board decided not to pursue. The merger agreement was terminated on July 7, 2026, after the Second Extended End Date passed.

• · The merger agreement was originally entered into on January 6, 2025.
• · The CMA conditioned clearance on the sale of Shutterstock's editorial business.
• · Getty Images' board unanimously resolved not to proceed with the editorial business sale process.
• · The termination occurred after the Second Extended End Date (July 6, 2026) passed.
• · The termination was effective July 7, 2026.

09-07-2026

Kyverna Therapeutics amended its Loan and Security Agreement with Oxford Finance LLC on July 8, 2026, extending the availability of the remaining $15.0 million of Term A Loans through December 31, 2026, in exchange for an upfront cash fee of $187,500. The amendment also provides for potential extensions of Term B and Term C loan tranches contingent on drawing the full remaining Term A amount, with new minimum revenue covenants beginning as early as Q2 2027. However, the company has not yet drawn the full $15.0 million, and if it does not, the original loan terms will continue to apply, indicating uncertainty about near-term capital needs.

• · The original Loan Facility was entered into on October 31, 2025.
• · The initial draw period for Term A Loans was originally up to June 30, 2026, now extended to December 31, 2026.
• · Term B Loan availability is contingent on achieving specified clinical milestones and drawing the full remaining $15.0M of Term A Loans.
• · Term C Loans are available in two $20.0M tranches, contingent on revenue and clinical milestones, with draw periods through March 31, 2028.
• · Minimum revenue covenants begin as early as the quarter ending June 30, 2027, depending on gross cash proceeds from other capital sources.
• · If the company does not draw the full $15.0M Term A, the original loan terms continue to apply.

09-07-2026

Enerpac Tool Group Corp. (EPAC) has entered into a definitive agreement to acquire SFE Group for approximately $472 million in cash, funded by cash on hand and an increased revolving credit facility (from $400M to $625M). SFE Group generated trailing twelve months sales of ~$170 million and adjusted EBITDA of ~$44 million, implying a purchase multiple of 10.6x adjusted EBITDA (9.5x including anticipated synergies). The acquisition is expected to close in Q1 FY2027, be accretive to FY2027 adjusted EPS, and expand Enerpac's total addressable market by ~$1 billion, while net debt-to-adjusted EBITDA is expected to be approximately 2.8x upon closing.

• · Acquisition expected to close in Q1 FY2027, subject to regulatory approvals.
• · Net debt-to-adjusted EBITDA expected to be approximately 2.8x upon closing.
• · SFE Group has approximately 350 employees globally at four production facilities and seven rental depots.
• · SFE Group serves industries including aerospace & defense, food & beverage, bio-pharma, oil & gas, manufacturing, utilities, power generation, semiconductor, maritime, mining, transportation, data centers, and hospitals.
• · Vinay Varma will continue to run SFE Group as President post-acquisition.
• · Enerpac will provide further details on its earnings conference call on July 8, 2026 at 7:30 am CT.

09-07-2026

Nauticus Robotics, Inc. filed a Certificate of Designation establishing up to 50,000 shares of Series D Convertible Preferred Stock, each with a stated value of $1,000 and a 10% per annum cumulative dividend. The Series D ranks senior to common stock and junior to existing Series A, B, and C preferred stock, and includes a conversion price with an absolute floor of $0.178 per share. The filing reflects a capital raise under a February 2026 securities purchase agreement, but no specific investment amount or closing date is disclosed.

• · Series D Preferred Stock ranks senior to Junior Securities (common stock) and junior to Series A, B, and C Preferred Stock.
• · Dividends accrue at 10% per annum on the sum of liquidation value plus unpaid accrued dividends, payable quarterly in kind or via capitalization.
• · Conversion price includes an absolute floor of $0.178 per share, subject to anti-dilution adjustments.
• · The filing references a Securities Purchase Agreement dated February 6, 2026, but no investment amount or closing date is provided.
• · Requisite stockholder approval under Nasdaq Listing Rule 5635(d) may be required for conversion share issuance above certain limits.

09-07-2026

Onfolio Holdings Inc. received a NASDAQ deficiency notice on July 2, 2026, for failing to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The company has a 180-day compliance period until December 29, 2026, to regain compliance by achieving a $1.00 closing bid price for at least ten consecutive business days. If it fails, it may qualify for an additional 180-day period subject to meeting other listing standards and effecting a reverse stock split if necessary.

• · The deficiency notice has no immediate effect on the listing or trading of the company's common stock on the NASDAQ Capital Market.
• · To qualify for a second compliance period, the company must meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market except the bid price requirement.
• · The company intends to consider all available options to regain compliance, including a potential reverse stock split.

09-07-2026

Hydrofarm Holdings Group, Inc. (HYFM) filed an 8-K on July 9, 2026, disclosing receipt of a Nasdaq Determination Letter regarding non-compliance with continued listing requirements, including minimum stockholders' equity and minimum bid price. The company intends to pursue a hearing with the Nasdaq Panel to appeal the findings. The filing highlights significant risks related to liquidity, indebtedness, and the ability to regain compliance, with no positive financial metrics reported.

• · The filing references risk factors from the company's Annual Report on Form 10-K filed March 27, 2026.
• · The company acknowledges risks including oversupply, product price fluctuations, and competitive industry pressures.
• · The company disclaims any obligation to update forward-looking statements.

09-07-2026

Prairie Operating Co. (PROP) received a Nasdaq notice on July 2, 2026, that its common stock has traded below the $1.00 minimum bid price for 30 consecutive business days, triggering a potential delisting. The company has an initial 180-day compliance period until December 29, 2026, to regain compliance by closing at or above $1.00 for ten consecutive days. If it fails, it may qualify for a second 180-day period, but a drop to $0.10 or below for ten consecutive days would trigger immediate delisting without any compliance period.

• · The delisting notice is based on Nasdaq Listing Rule 5550(a)(2) (Minimum Bid Price Requirement).
• · If the stock trades at or below $0.10 for ten consecutive trading days, Nasdaq will immediately issue a delisting determination and suspend trading, making the company ineligible for any compliance period.
• · To qualify for a second 180-day compliance period, the company must meet all other initial listing standards for The Nasdaq Capital Market except the bid price requirement and provide written notice of intent to cure.

09-07-2026

Splash Beverage Group received NYSE American approval of its compliance plan to address shareholders' equity deficiencies under Sections 1003(a)(i)-(iii). The company has until January 29, 2027 to regain compliance, and its common stock (SBEV) continues trading on the NYSE American in the interim. However, failure to meet the plan's milestones or regain compliance by the deadline could lead to delisting proceedings.

• · The compliance plan was submitted on May 29, 2026 and accepted by NYSE on July 8, 2026.
• · The company must regain compliance with shareholders' equity requirements under Sections 1003(a)(i), (ii), and (iii) of the NYSE American Company Guide.
• · No immediate impact on listing; shares continue trading under ticker SBEV.
• · If compliance is not achieved by January 29, 2027, or if progress is insufficient, delisting proceedings may be initiated.